Barrett & Company’s Teladoc Health TDOC Stock Holding History

Barrett & Company’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254	Hold	30	–	–	﹤0.01%	695
2026 Q1	$164	Hold	30	–	–	﹤0.01%	643
2025 Q4	$210	Sell	30 -200	-87%	-$1.57K	﹤0.01%	652
2025 Q3	$1.78K	Hold	230	–	–	﹤0.01%	590
2025 Q2	$2K	Hold	230	–	–	﹤0.01%	581
2025 Q1	$1.83K	Hold	230	–	–	﹤0.01%	556
2024 Q4	$2.09K	Hold	230	–	–	﹤0.01%	553
2024 Q3	$2.11K	Hold	230	–	–	﹤0.01%	534
2024 Q2	$2.25K	Hold	230	–	–	﹤0.01%	537
2024 Q1	$3.47K	Hold	230	–	–	﹤0.01%	517
2023 Q4	$4.96K	Hold	230	–	–	﹤0.01%	473
2023 Q3	$4.28K	Hold	230	–	–	﹤0.01%	493
2023 Q2	$5.82K	Hold	230	–	–	﹤0.01%	459
2023 Q1	$5.96K	Buy	230 +50	+28%	+$1.34K	﹤0.01%	432
2022 Q4	$4.26K	Hold	180	–	–	﹤0.01%	461
2022 Q3	$4.26K	Buy	+180	New	+$6.32K	﹤0.01%	461

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Barrett & Company's TDOC Position: Q2 2026 in Review

Barrett & Company held its Teladoc Health (TDOC) position steady in Q2 2026 at 30 shares worth $254. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Barrett & Company first reported a position in TDOC in Q3 2022 and has held it in 16 quarters since. The position peaked at $5.96K in Q1 2023. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Barrett & Company held 30 shares of Teladoc Health worth $254 as of Q2 2026.
Barrett & Company left its Teladoc Health share count unchanged in Q2 2026.
Teladoc Health made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #695 holding.
Barrett & Company first reported a position in Teladoc Health in Q3 2022 and has held it in 16 quarters since.
Barrett & Company's Teladoc Health position peaked at $5.96K in Q1 2023.
348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.